according to your buddy Dav, any biotech success is everybody’s success, so if that were really the case (as opposed to his egregious attempt to attach himself to someone else’s success - I haven’t seen him publicly congratulate the MSB team on an FDA approval after he slated management there), why would you be opposed to or want to belittle IMU’s potential for an FDA approval with Azer-cel?
3 complete responses for patients isn't good enough?
“patents, patients and patience” you say lol completely disingenuous on your part.
note Imugene has now dosed multiple Australian patients in trials spanning the US/ and Aus, something you guys are yet to do.
IMU Price at posting:
3.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)